Anthony Hunt
Known title: Chief Executive OfficerCIK: 0001606030
Anthony Hunt's purchase track record
Anthony Hunt has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 6/14/2024 | RGEN | $248K | +11.4% | +24.5% | +11.4% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 6, 2026
Repligen Completes BioLife Solutions Acquisition. Repligen has finalized its acquisition of BioLife Solutions, a move that follows shareholder approval of the merger. This transaction expands Repligen's portfolio in the biopharmaceutical sector. The stock recently reached a 52-week high, reflecting market interest in the company's growth strategy.
Transaction History
| BLFS | ▼ Sell | Other | 15,046 | — | 10/6/2026 | View on chart |
| MASS | ▲ Buy | Option Exercise | 14,083 | — | 6/10/2026 | View on chart |
| RGEN | ▼ Sell | Tax Withholding | 9,897 | $1.2M | 3/2/2026 | View on chart |
| BLFS | ▲ Buy | Grant | 8,170 | — | 2/24/2026 | View on chart |
| RGEN | ▼ Sell | Other | 2,000 | — | 12/4/2025 | View on chart |
| RGEN | ▼ Sell | Open Market | 1,784 | $269K | 11/13/2025 | View on chart |
| RGEN | ▼ Sell | Open Market | 2,100 | $320K | 11/13/2025 | View on chart |
| RGEN | ▼ Sell | Open Market | 2,923 | $448K | 11/13/2025 | View on chart |
| RGEN | ▼ Sell | Open Market | 2,500 | $386K | 11/13/2025 | View on chart |
| RGEN | ▼ Sell | Open Market | 3,000 | $466K | 11/13/2025 | View on chart |
| RGEN | ▼ Sell | Open Market | 5,737 | $896K | 11/13/2025 | View on chart |
| RGEN | ▼ Sell | Open Market | 1,956 | $307K | 11/13/2025 | View on chart |
| RGEN | ▲ Buy | Option Exercise | 2,952 | $100K | 11/13/2025 | View on chart |
| RGEN | ▲ Buy | Option Exercise | 25,000 | $847K | 11/12/2025 | View on chart |
| RGEN | ▼ Sell | Open Market | 3,741 | $580K | 11/12/2025 | View on chart |
| RGEN | ▼ Sell | Open Market | 4,740 | $739K | 11/12/2025 | View on chart |
| RGEN | ▼ Sell | Open Market | 4,959 | $777K | 11/12/2025 | View on chart |
| RGEN | ▼ Sell | Open Market | 11,096 | $1.8M | 11/12/2025 | View on chart |
| RGEN | ▼ Sell | Open Market | 464 | $74K | 11/12/2025 | View on chart |
| RGEN | ▲ Buy | Option Exercise | 20,000 | $677K | 9/10/2025 | View on chart |
| RGEN | ▼ Sell | Open Market | 96 | $11K | 9/10/2025 | View on chart |
| RGEN | ▼ Sell | Open Market | 1,108 | $131K | 9/10/2025 | View on chart |
| RGEN | ▼ Sell | Open Market | 3,262 | $390K | 9/10/2025 | View on chart |
| RGEN | ▼ Sell | Open Market | 14,882 | $1.8M | 9/10/2025 | View on chart |
| RGEN | ▼ Sell | Open Market | 7,584 | $921K | 9/10/2025 | View on chart |
| RGEN | ▼ Sell | Open Market | 2,179 | $266K | 9/10/2025 | View on chart |
| MASS | ▲ Buy | Option Exercise | 11,364 | — | 6/11/2025 | View on chart |
| RGEN | ▼ Sell | Open Market | 2,043 | $251K | 5/15/2025 | View on chart |
| RGEN | ▼ Sell | Open Market | 17,596 | $2.2M | 5/15/2025 | View on chart |
| RGEN | ▼ Sell | Open Market | 6,533 | $812K | 5/15/2025 | View on chart |
| RGEN | ▼ Sell | Open Market | 268 | $34K | 5/15/2025 | View on chart |
| RGEN | ▼ Sell | Open Market | 7 | $889 | 5/15/2025 | View on chart |
| BLFS | ▲ Buy | Grant | 6,876 | — | 3/18/2025 | View on chart |
| RGEN | ▲ Buy | Option Exercise | 5,000 | $169K | 3/17/2025 | View on chart |
| RGEN | ▲ Buy | Option Exercise | 21,756 | $1.3M | 3/17/2025 | View on chart |
| RGEN | ▼ Sell | Open Market | 60 | $9K | 3/17/2025 | View on chart |
| RGEN | ▼ Sell | Open Market | 100 | $15K | 3/17/2025 | View on chart |
| RGEN | ▼ Sell | Open Market | 2,518 | $380K | 3/17/2025 | View on chart |
| RGEN | ▼ Sell | Open Market | 6,176 | $939K | 3/17/2025 | View on chart |
| RGEN | ▼ Sell | Open Market | 15,619 | $2.4M | 3/17/2025 | View on chart |
| RGEN | ▼ Sell | Open Market | 2,283 | $351K | 3/17/2025 | View on chart |
| RGEN | ▼ Sell | Tax Withholding | 10,142 | $1.6M | 3/3/2025 | View on chart |
| MASS | ▲ Buy | Option Exercise | 2,058 | — | 3/2/2025 | View on chart |
| RGEN | ▼ Sell | Tax Withholding | 2,825 | $442K | 2/27/2025 | View on chart |
| RGEN | ▼ Sell | Tax Withholding | 2,380 | $392K | 2/24/2025 | View on chart |
| RGEN | ▲ Buy | Option Exercise | 11,808 | $400K | 12/5/2024 | View on chart |
| RGEN | ▲ Buy | Option Exercise | 24,246 | $821K | 11/21/2024 | View on chart |
| RGEN | ▼ Sell | Open Market | 24,246 | $3.4M | 11/21/2024 | View on chart |
| RGEN | ▲ Buy | Option Exercise | 10,000 | $339K | 9/10/2024 | View on chart |
| RGEN | ▼ Sell | Open Market | 1,495 | $215K | 9/10/2024 | View on chart |
| RGEN | ▼ Sell | Open Market | 9,369 | $1.4M | 9/10/2024 | View on chart |
| RGEN | ▼ Sell | Open Market | 10,723 | $1.6M | 9/10/2024 | View on chart |
| RGEN | ▼ Sell | Open Market | 604 | $89K | 9/10/2024 | View on chart |
| RGEN | ▼ Sell | Other | 13,146 | $0 | 9/3/2024 | View on chart |
| RGEN | ▲ Buy | Open Market | 2,000 | $248K | 6/14/2024 | View on chart |
| MASS | ▲ Buy | Option Exercise | 7,777 | — | 6/12/2024 | View on chart |
| RGEN | ▼ Sell | Open Market | 4,274 | $711K | 5/21/2024 | View on chart |
| RGEN | ▼ Sell | Open Market | 4,008 | $670K | 5/21/2024 | View on chart |
| RGEN | ▼ Sell | Open Market | 3,933 | $662K | 5/21/2024 | View on chart |
| RGEN | ▼ Sell | Open Market | 2,963 | $502K | 5/21/2024 | View on chart |
| RGEN | ▼ Sell | Open Market | 3,925 | $667K | 5/21/2024 | View on chart |
| RGEN | ▼ Sell | Open Market | 969 | $166K | 5/21/2024 | View on chart |
| RGEN | ▼ Sell | Gift | 2,000 | $0 | 3/18/2024 | View on chart |
| RGEN | ▲ Buy | Option Exercise | 1 | $17 | 3/8/2024 | View on chart |
| RGEN | ▼ Sell | Open Market | 3,377 | $660K | 3/8/2024 | View on chart |
| RGEN | ▼ Sell | Open Market | 6,228 | $1.2M | 3/8/2024 | View on chart |
| RGEN | ▼ Sell | Open Market | 1,666 | $329K | 3/8/2024 | View on chart |
| RGEN | ▼ Sell | Open Market | 1,347 | $267K | 3/8/2024 | View on chart |
| RGEN | ▼ Sell | Open Market | 1,822 | $364K | 3/8/2024 | View on chart |
| RGEN | ▼ Sell | Open Market | 1,305 | $262K | 3/8/2024 | View on chart |
| RGEN | ▼ Sell | Open Market | 806 | $163K | 3/8/2024 | View on chart |
| RGEN | ▼ Sell | Open Market | 156 | $32K | 3/8/2024 | View on chart |
| RGEN | ▼ Sell | Tax Withholding | 2,867 | $561K | 3/7/2024 | View on chart |
| RGEN | ▼ Sell | Tax Withholding | 7,275 | $1.4M | 3/5/2024 | View on chart |
| RGEN | ▼ Sell | Tax Withholding | 1,111 | $216K | 3/4/2024 | View on chart |
| MASS | ▲ Buy | Option Exercise | 2,057 | — | 3/4/2024 | View on chart |
| RGEN | ▼ Sell | Tax Withholding | 3,322 | $637K | 3/1/2024 | View on chart |
| RGEN | ▲ Buy | Grant | 2,504 | $0 | 2/29/2024 | View on chart |
| RGEN | ▲ Buy | Grant | 19,719 | $0 | 2/27/2024 | View on chart |
| RGEN | ▼ Sell | Gift | 1,000 | $0 | 11/14/2023 | View on chart |
| MASS | ▲ Buy | Option Exercise | 4,771 | — | 6/14/2023 | View on chart |
| RGEN | ▲ Buy | Grant | 18,584 | $0 | 3/3/2023 | View on chart |
| RGEN | ▼ Sell | Tax Withholding | 8,244 | $1.5M | 3/3/2023 | View on chart |
| RGEN | ▲ Buy | Grant | 19,393 | $0 | 3/2/2023 | View on chart |
| RGEN | ▼ Sell | Tax Withholding | 6,670 | $1.2M | 3/2/2023 | View on chart |
| MASS | ▲ Buy | Option Exercise | 2,058 | — | 3/2/2023 | View on chart |
| RGEN | ▼ Sell | Tax Withholding | 2,748 | $476K | 2/28/2023 | View on chart |
| RGEN | ▼ Sell | Tax Withholding | 3,273 | $568K | 2/28/2023 | View on chart |
| RGEN | ▲ Buy | Option Exercise | 25,000 | $847K | 11/11/2022 | View on chart |
| RGEN | ▼ Sell | Open Market | 25,000 | $5.0M | 11/11/2022 | View on chart |
| RGEN | ▲ Buy | Option Exercise | 10,000 | $339K | 9/8/2022 | View on chart |
| RGEN | ▼ Sell | Open Market | 824 | $181K | 9/8/2022 | View on chart |
| RGEN | ▼ Sell | Open Market | 1,235 | $274K | 9/8/2022 | View on chart |
| RGEN | ▼ Sell | Open Market | 720 | $160K | 9/8/2022 | View on chart |
| RGEN | ▼ Sell | Open Market | 1,389 | $310K | 9/8/2022 | View on chart |
| RGEN | ▼ Sell | Open Market | 6,626 | $1.5M | 9/8/2022 | View on chart |
| RGEN | ▼ Sell | Open Market | 10,490 | $2.4M | 9/8/2022 | View on chart |
| RGEN | ▼ Sell | Open Market | 4,873 | $1.1M | 9/8/2022 | View on chart |
| RGEN | ▼ Sell | Open Market | 245 | $56K | 9/8/2022 | View on chart |
| RGEN | ▲ Buy | Option Exercise | 5,000 | $169K | 7/21/2022 | View on chart |
| RGEN | ▲ Buy | Option Exercise | 15,154 | $491K | 7/21/2022 | View on chart |
| RGEN | ▼ Sell | Open Market | 24,802 | $5.0M | 7/21/2022 | View on chart |
| RGEN | ▼ Sell | Tax Withholding | 7,292 | $1.4M | 3/1/2022 | View on chart |
| RGEN | ▼ Sell | Tax Withholding | 3,170 | $624K | 2/28/2022 | View on chart |
| RGEN | ▲ Buy | Grant | 30,074 | $0 | 2/28/2022 | View on chart |
| RGEN | ▼ Sell | Tax Withholding | 13,368 | $2.6M | 2/28/2022 | View on chart |
| RGEN | ▼ Sell | Tax Withholding | 2,754 | $542K | 2/27/2022 | View on chart |
| RGEN | ▲ Buy | Grant | 15,855 | $0 | 2/24/2022 | View on chart |
| RGEN | ▼ Sell | Tax Withholding | 1,170 | $221K | 2/24/2022 | View on chart |
| RGEN | ▲ Buy | Option Exercise | 10,000 | $324K | 11/18/2021 | View on chart |
| RGEN | ▼ Sell | Open Market | 2,061 | $565K | 11/18/2021 | View on chart |
| RGEN | ▼ Sell | Open Market | 1,955 | $537K | 11/18/2021 | View on chart |
| RGEN | ▼ Sell | Open Market | 4,017 | $1.1M | 11/18/2021 | View on chart |
| RGEN | ▼ Sell | Open Market | 1,732 | $480K | 11/18/2021 | View on chart |
| RGEN | ▼ Sell | Open Market | 6,024 | $1.7M | 11/18/2021 | View on chart |
| RGEN | ▼ Sell | Open Market | 970 | $271K | 11/18/2021 | View on chart |
| RGEN | ▼ Sell | Open Market | 596 | $168K | 11/18/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 7, 2026
Analyst Pieces Highlight BioLife Solutions' Customer Retention, Momentum
Two analyst pieces this week focused on BioLife Solutions. Diamond Hill pointed to the company's high switching costs, suggesting customers face barriers to moving to competitors, which can support steady revenue. ChartMill separately noted the stock shows strong growth momentum along with a potential breakout setup. The stock is trading near the lower end of its 52-week range, while analysts maintain an average price target around $31, well above current levels.
Analyst Pieces Highlight BioLife Solutions' Customer Retention, Momentum. Two analyst pieces this week focused on BioLife Solutions. Diamond Hill pointed to the company's high switching costs, suggesting customers face barriers to moving to competitors, which can support steady revenue. ChartMill separately noted the stock shows strong growth momentum along with a potential breakout setup. The stock is trading near the lower end of its 52-week range, while analysts maintain an average price target around $31, well above current levels.